Logos Global Management LP
CIK 1792126 · Holdings on Jun 30, 2025 · First reported Aug 14, 2025
Top ten holdings
Q2 2025- IDYA9.39%
- AKRO8.55%
- RVMD8.35%
- JAZZ6.38%
- IRON4.95%
- RNA3.60%
- KROS3.57%
- BIIB3.36%
- UTHR3.26%
- ARVN3.24%
Share classes counted separately54.65%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- JANXWeight decreased · -4.83 pp7.92% → 3.09%Shares -650.00K (-39.39%)
- RNAWeight increased · +1.76 pp1.84% → 3.60%Shares +600.00K (+171.43%)
- RVMDWeight decreased · -1.71 pp10.06% → 8.35%Shares +100.00K (+6.25%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | IDYAIDEAYA BIOSCIENCES INC View history and evidence | $70.31M | 9.39% | 3.35M shares | 10.19% → 9.39%-0.80 pp -155.00K (-4.43%) | Reduced | ↗▾ |
| 02 | AKROAKERO THERAPEUTICS INC View history and evidence | $64.03M | 8.55% | 1.20M shares | 8.64% → 8.55%-0.09 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | RVMDREVOLUTION MEDICINES INC View history and evidence | $62.54M | 8.35% | 1.70M shares | 10.06% → 8.35%-1.71 pp +100.00K (+6.25%) | Added | ↗▾ |
| 04 | JAZZJAZZ PHARMACEUTICALS PLCSHS USD View history and evidence | $47.75M | 6.38% | 450.00K shares | Prior unavailable +450.00K | New | ↗▾ |
| 05 | IRONDISC MEDICINE INC View history and evidence | $37.07M | 4.95% | 700.00K shares | 3.48% → 4.95%+1.47 pp +305.66K (+77.51%) | Added | ↗▾ |
| 06 | RNAAVIDITY BIOSCIENCES INC View history and evidence | $26.98M | 3.60% | 950.00K shares | 1.84% → 3.60%+1.76 pp +600.00K (+171.43%) | Added | ↗▾ |
| 07 | KROSKEROS THERAPEUTICS INC View history and evidence | $26.70M | 3.57% | 2.00M shares | 3.62% → 3.57%-0.05 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | BIIBBIOGEN INC View history and evidence | $25.12M | 3.36% | 200.00K shares | Prior unavailable +200.00K | New | ↗▾ |
| 09 | UTHRUNITED THERAPEUTICS CORP View history and evidence | $24.42M | 3.26% | 85.00K shares | Prior unavailable +85.00K | New | ↗▾ |
| 10 | ARVNARVINAS INC View history and evidence | $24.29M | 3.24% | 3.30M shares | Prior unavailable +3.30M | New | ↗▾ |
Options overlay 6
$155.19M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Call | 1.00M | $82.93M | +1.00M | ▾ |
TEVANTEVA PHARMACEUTICAL-SP ADRSPONSORED ADS View history and evidence | Call | 1.50M | $25.14M | +1.50M | ▾ |
APLSAPELLIS PHARMACEUTICALS INC View history and evidence | Call | 1.00M | $17.31M | +1.00M | ▾ |
3 / 6 options · preview only
Exited positions 14
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| NUVL NUVALENT INC-A | Non-derivative | -500,000 | -$35.46M | SEC filing ↗ | SEC filing ↗ |
| TEVAN TEVA PHARMACEUTICAL-SP ADR | Non-derivative | -1,700,000 | -$26.13M | SEC filing ↗ | SEC filing ↗ |
| XENE XENON PHARMACEUTICALS INC | Non-derivative | -650,000 | -$21.81M | SEC filing ↗ | SEC filing ↗ |
3 / 14 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1792126 · Period 2025-06-30
Data loaded 2026-09-23 · First reported 2025-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 903799594
}Research all 51 reported holdings.
This page includes 30 of 51 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 51 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1792126","quarter":"2025Q2","page_size":100}
get_institutional_manager_history
{"cik":"1792126","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.